Xiao‐Dong Yin

517 citations
17 papers · 381 indexed · h-index 11
Topics
Natural product bioactivities and synthesis (2 papers)Estrogen and related hormone effects (2 papers)Circular RNAs in diseases (2 papers)
Partner nations
China

In The Last Decade

Xiao‐Dong Yin

17 papers receiving 372 citations

Peers

Xiao‐Dong Yin
Comparison fields: 5 of 104
  • Molecular Biology 125
  • Biomaterials 94
  • Pharmaceutical Science 59
  • Biomedical Engineering 56
  • Cancer Research 42
Replace Weiguo Tan with:
Weiguo Tan China
S. Bahadur India
Shanshan He China
Sanjay Rathod United States
Parastoo Tarighi Iran
Zohreh Jahanafrooz Iran
Chayanin Pratoomsoot Thailand
Jerome H. Gass United States
Lois E. Bolcsak United States
Amit Kumar Singh India
Xiao‐Dong Yin relative to Weiguo Tan China Weiguo Tan's profile →
Citations per field
00.5×3.8×
Weiguo Tan · 1×
Citations per year

Countries citing papers authored by Xiao‐Dong Yin

Since Specialization
Citations

This map shows the geographic impact of Xiao‐Dong Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao‐Dong Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao‐Dong Yin more than expected).

Fields of papers citing papers by Xiao‐Dong Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao‐Dong Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao‐Dong Yin. The network helps show where Xiao‐Dong Yin may publish in the future.

Co-authorship network of co-authors of Xiao‐Dong Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao‐Dong Yin. A scholar is included among the top collaborators of Xiao‐Dong Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao‐Dong Yin. Xiao‐Dong Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 2
2 1
3 5
4 15
5 7
6 20
7 57
8 16
9 3
10 12
11 65
12 21
13 17
14 21
15 7
16 92
17 20

About Xiao‐Dong Yin

Xiao‐Dong Yin is a scholar working on Cancer Research, Reproductive Medicine and Pathology and Forensic Medicine, having authored 17 papers that have together received 381 indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (2 papers), Estrogen and related hormone effects (2 papers) and Circular RNAs in diseases (2 papers). The work is most often cited by research in Pharmaceutical Science (59 citations), Biomaterials (94 citations) and Drug Discovery (1 citation). Xiao‐Dong Yin has collaborated with scholars based in China. Frequent co-authors include Bin Lü, Hong Yang, Chao Ruo-bing, Honghui Liu, Jing Wang, Cailian Wang, Juan Li, Yu Duan, Yan-wen Liu and Xiu Zhang. Their work appears in journals such as The Science of The Total Environment, International Journal of Pharmaceutics and European Journal of Pharmaceutical Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026